Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung

Abstract Idiopathic pulmonary fibrosis (IPF) is a severe disorder leading to progressive and irreversible loss of pulmonary function. In this study we investigated the anti-fibrotic effect of vitamin D using a mouse model of IPF. Lung fibrosis was induced with bleomycin in vitamin D-sufficient and v...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jianjun Chang, Hongguang Nie, Xin Ge, Jie Du, Weicheng Liu, Xue Li, Yue Sun, Xinzhi Wei, Zhe Xun, Yan Chun Li
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6b82009ba29f42d6a720d696b13be5a8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6b82009ba29f42d6a720d696b13be5a8
record_format dspace
spelling oai:doaj.org-article:6b82009ba29f42d6a720d696b13be5a82021-12-02T15:10:50ZVitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung10.1038/s41598-021-96152-72045-2322https://doaj.org/article/6b82009ba29f42d6a720d696b13be5a82021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96152-7https://doaj.org/toc/2045-2322Abstract Idiopathic pulmonary fibrosis (IPF) is a severe disorder leading to progressive and irreversible loss of pulmonary function. In this study we investigated the anti-fibrotic effect of vitamin D using a mouse model of IPF. Lung fibrosis was induced with bleomycin in vitamin D-sufficient and vitamin D-deficient C57BL/6 mice. We found that treatment with active vitamin D analog paricalcitol prevented mouse body weight loss and alleviated lung fibrosis, whereas vitamin D deficiency severely aggravated lung injury. At the molecular level, paricalcitol treatment suppressed the induction of fibrotic inducer TGF-β and extracellular matrix proteins α-SMA, collagen type I and fibronectin in the lung, whereas vitamin D deficiency exacerbated the induction of these proteins. Interestingly, bleomycin treatment activated the local renin–angiotensin system (RAS) in the lung, manifested by the induction of renin, angiotensinogen, angiotensin II and angiotensin receptor type 1 (AT1R). Paricalcitol treatment suppressed the induction of these RAS components, whereas vitamin D deficiency enhanced the activation of the lung RAS. We also showed that treatment of bleomycin-induced vitamin D-deficient mice with AT1R antagonist losartan relieved weight loss, substantially ameliorated lung fibrosis and markedly blocked TGF-β induction in the lung. Moreover, we demonstrated that in lung fibroblast cultures, TGF-β and angiotensin II synergistically induced TGF-β, AT1R, α-SMA, collagen type I and fibronectin, whereas 1,25-dihydroxyvitamin D markedly suppressed the induction of these fibrotic markers. Collectively, these observations strongly suggest that vitamin D mitigates lung fibrosis by blocking the activation of the lung RAS in this mouse model of IPF.Jianjun ChangHongguang NieXin GeJie DuWeicheng LiuXue LiYue SunXinzhi WeiZhe XunYan Chun LiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jianjun Chang
Hongguang Nie
Xin Ge
Jie Du
Weicheng Liu
Xue Li
Yue Sun
Xinzhi Wei
Zhe Xun
Yan Chun Li
Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung
description Abstract Idiopathic pulmonary fibrosis (IPF) is a severe disorder leading to progressive and irreversible loss of pulmonary function. In this study we investigated the anti-fibrotic effect of vitamin D using a mouse model of IPF. Lung fibrosis was induced with bleomycin in vitamin D-sufficient and vitamin D-deficient C57BL/6 mice. We found that treatment with active vitamin D analog paricalcitol prevented mouse body weight loss and alleviated lung fibrosis, whereas vitamin D deficiency severely aggravated lung injury. At the molecular level, paricalcitol treatment suppressed the induction of fibrotic inducer TGF-β and extracellular matrix proteins α-SMA, collagen type I and fibronectin in the lung, whereas vitamin D deficiency exacerbated the induction of these proteins. Interestingly, bleomycin treatment activated the local renin–angiotensin system (RAS) in the lung, manifested by the induction of renin, angiotensinogen, angiotensin II and angiotensin receptor type 1 (AT1R). Paricalcitol treatment suppressed the induction of these RAS components, whereas vitamin D deficiency enhanced the activation of the lung RAS. We also showed that treatment of bleomycin-induced vitamin D-deficient mice with AT1R antagonist losartan relieved weight loss, substantially ameliorated lung fibrosis and markedly blocked TGF-β induction in the lung. Moreover, we demonstrated that in lung fibroblast cultures, TGF-β and angiotensin II synergistically induced TGF-β, AT1R, α-SMA, collagen type I and fibronectin, whereas 1,25-dihydroxyvitamin D markedly suppressed the induction of these fibrotic markers. Collectively, these observations strongly suggest that vitamin D mitigates lung fibrosis by blocking the activation of the lung RAS in this mouse model of IPF.
format article
author Jianjun Chang
Hongguang Nie
Xin Ge
Jie Du
Weicheng Liu
Xue Li
Yue Sun
Xinzhi Wei
Zhe Xun
Yan Chun Li
author_facet Jianjun Chang
Hongguang Nie
Xin Ge
Jie Du
Weicheng Liu
Xue Li
Yue Sun
Xinzhi Wei
Zhe Xun
Yan Chun Li
author_sort Jianjun Chang
title Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung
title_short Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung
title_full Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung
title_fullStr Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung
title_full_unstemmed Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung
title_sort vitamin d suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin–angiotensin system in the lung
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/6b82009ba29f42d6a720d696b13be5a8
work_keys_str_mv AT jianjunchang vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
AT hongguangnie vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
AT xinge vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
AT jiedu vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
AT weichengliu vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
AT xueli vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
AT yuesun vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
AT xinzhiwei vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
AT zhexun vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
AT yanchunli vitamindsuppressesbleomycininducedpulmonaryfibrosisbytargetingthelocalreninangiotensinsysteminthelung
_version_ 1718387694475673600